Amaç: Toplumumuzun bir bölümünde inançları gereği insanlar baş ve ekstremitelerin kapalı olduğu giysiler tercih etmektedir. Bu çalışmada, primer hiperparatiroidizm (PHPT) tanısı olanlarda güneş ışınlarına maruziyet ile D vitamini (DV) arasındaki ilişkiyi araştırmayı amaçladık. Gereç ve Yöntemler: Haziran 2014-Ağustos 2021 tarihleri arasında Dicle Üniversitesi Tıp Fakültesi Erişkin Endokrin Birimine başvuran ve PHPT tanısı konulan hastaların DV düzeyleri kaydedildi. Bu kişiler, baş ve ekstremitelerin güneşe olan maruziyet durumuna göre gruplara ayrılarak kategorize edildi. Gruplar; paratiroid hormon (PTH), 25-hidroksivitamin D, kalsiyum, fosfor, tiroid hormonları ile diğer biyokimyasal parametreler uygun istatistiksel yöntemler kullanılarak karşılaştırıldı. Bulgular: Toplam 76 kişinin 66'sı (%86,8) kadın, 10'u (%13,2) erkek idi. Bunlar içerisinde Grup 1'de güneşe maruziyeti olan 18 (%23,7) kişinin yaş ortalaması 40,2±13,1 (yıl), Grup 2'de güneşe maruziyeti az olan 58 (%76,3) kişinin yaşları ortalaması ise 52,6±12,3 (yıl) idi. Güneşe maruziyeti az olanların tamamı kadın iken güneşe maruziyetin olduğu grubun 10'u (%55,6) erkek, 8'i (%44,4) kadın idi. PHPT tanısı olan hastalarda DV düzeyleri <30 ng/mL olanların oranı %89,7, 20-29 ng/mL olanların oranı %10,3, <20 ng/mL olanların oranı %79,4, <10 ng/mL olanların oranı ise %42,6 bulundu. Gruplar arasında DV düzeyleri açısından farklılık yoktu (p: 0,156). Sonuç: PHPT olan hastalarda güneşe maruziyet bakımından DV düzeylerinde anlamlı fark bulunmadı ancak güneşe maruziyetin az olduğu grupta daha yüksek PTH ve daha düşük DV düzeylerinin olduğu gözlendi.
Anahtar Kelimeler: Primer hiperparatiroidizm; vitamin D eksikliği; 25-hidroksivitamin D
Objective: In a part of our society, people prefer clothes that cover the head and extremities due to their beliefs. In this study, we aimed to investigate the relationship between exposure to sunlight and vitamin D (VD) in patients with primary hyperparathyroidism (PHPT). Material and Methods: The VD levels of the patients diagnosed with PHPT who applied to the adult Endocrine Unit of Dicle University Faculty of Medicine between June 2014 and August 2021 were recorded. These individuals were categorized according to the sun exposure of the head and extremities. The groups; parathyroid hormone (PTH), 25- hydroxyvitamin D, calcium, phosphorus, thyroid hormones and other biochemical parameters were compared using appropriate statistical methods. Results: Of the 76 people, 66 (86.8%) were female and 10 (13.2%) were male. Among these, the mean age of 18 people (23.7%) with sun exposure in Group 1 was 40.2±13.1 (years), and the mean age of 58 people (76.3%) with low sun exposure in Group 2 was 52.6±12.3 (years). All of those with less exposure to the sun were women; Ten (55.6%) of the group with sun exposure were male and 8 (44.4%) were female. In patients diagnosed with PHPT, the rate of VD levels <30 ng/mL was 89.7%, the rate of 20-29 ng/mL was 10.3%, the rate of <20 ng/mL was 79.4%, and the rate of <10 ng/mL was 42.6%. There was no difference between the groups in terms of VD levels (p: 0.156). Conclusion: There was no significant difference in VD levels in terms of sun exposure in patients with PHPT; but higher PTH and lower VD levels were observed in the group with less sun exposure.
Keywords: Primary hyperparathyroidism; vitamin D deficiency; 25-hydroxyvitamin D
- Souberbielle JC, Maury E, Friedlander G, Cormier C. Vitamin D and primary hyperparathyroidism (PHPT). J Steroid Biochem Mol Biol. 2010;121(1-2):199-203. [Crossref] [PubMed]
- Percivale A, Gnerre P, Damonte G, Buscaglia S, Monachesi M, Parodi L, et al. Primary hyperparathyroidism: epidemiology, clinical features, diagnostic tools and current management. Italian Journal of Medicine. 2015;9:330-45. [Crossref]
- Khan AA, Hanley DA, Rizzoli R, Bollerslev J, Young JE, Rejnmark L, et al. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int. 2017;28(1):1-19. [Crossref] [PubMed] [PMC]
- Walker MD, Silverberg SJ. Primary hyperparathyroidism. Nat Rev Endocrinol. 2018;14(2):115-25. [Crossref] [PubMed] [PMC]
- Landry CS, Ruppe MD, Grubbs EG. Vitamin D receptors and parathyroid glands. Endocr Pract. 2011;17 Suppl 1:63-8. [Crossref] [PubMed]
- Walker MD, Bilezikian JP. Primary hyperparathyroidism: recent advances. Curr Opin Rheumatol. 2018;30(4):427-39. [Crossref] [PubMed]
- Silva BC, Cusano NE, Bilezikian JP. Primary hyperparathyroidism. Best Pract Res Clin Endocrinol Metab. 2018;32(5):593-607. [Crossref] [PubMed]
- Masi L. Primary Hyperparathyroidism. Front Horm Res. 2019;51:1-12. [Crossref] [PubMed]
- Souberbielle JC, Cavalier E, Cormier C. How to manage an isolated elevated PTH? Ann Endocrinol (Paris). 2015;76(2):134-41. [Crossref] [PubMed]
- Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al; Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-30. Erratum in: J Clin Endocrinol Metab. 2011;96(12):3908. [Crossref] [PubMed]
- Vélayoudom-Céphise FL, Wémeau JL. Primary hyperparathyroidism and vitamin D deficiency. Ann Endocrinol (Paris). 2015;76(2):153-62. Erratum in: Ann Endocrinol (Paris). 2015;76(3):289. [Crossref] [PubMed]
- Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium. Dietary Reference Intakes for Calcium and Vitamin D. Ross AC, Taylor CL, Yaktine AL, Del Valle HB, editors. Washington (DC): National Academies Press (US); 2011. [PubMed]
- Rosen CJ, Gallagher JC. The 2011 IOM report on vitamin D and calcium requirements for north america: clinical implications for providers treating patients with low bone mineral density. J Clin Densitom. 2011;14(2):79-84. [Crossref] [PubMed]
- Maharaj J, Haas MJ, Wehmeier KR. Primary hyperparathyroidism and vitamin D in African Americans. Endocr Pract. 2012;18(6):947-53. [Crossref] [PubMed]
- Moosgaard B, Vestergaard P, Heickendorff L, Melsen F, Christiansen P, Mosekilde L. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clin Endocrinol (Oxf). 2005;63(5):506-13. [Crossref] [PubMed]
- Rao DS, Honasoge M, Divine GW, Phillips ER, Lee MW, Ansari MR, et al. Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications. J Clin Endocrinol Metab. 2000;85(3):1054-8. [Crossref] [PubMed]
- Öncül Börekçi N. D Vitamini eksikliği ile ilgili güncel bilgiler [Current information on vitamin D deficiency]. The Journal of Turkish Family Physician. 2019;10(1):35-42. [Crossref]
- Cigerli O, Parildar H, Unal AD, Tarcin O, Erdal R, Guvener Demirag N. Vitamin D deficiency is a problem for adult out-patients? A university hospital sample in Istanbul, Turkey. Public Health Nutr. 2013;16(7):1306-13. [Crossref] [PubMed]
- Alagöl F, Shihadeh Y, Boztepe H, Tanakol R, Yarman S, Azizlerli H, et al. Sunlight exposure and vitamin D deficiency in Turkish women. J Endocrinol Invest. 2000;23(3):173-7. [Crossref] [PubMed]
.: Process List